Mammary gland development, reproductive history, and breast cancer risk

Cancer Research

Volumn 59, Issue 7 SUPPL., 1999, Pages

  Chodosh, Lewis A ^a   D'Cruz, Celina M ^a   Gardner, Heather Perry ^a   Ha, Seung I ^a   Marquis, Sandra T ^a   Rajan, Jayant V ^a   Stairs, Douglas B ^a   Wang, James Y ^a   Wang, Man ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN KINASE;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER RISK; CELL CYCLE; CONFERENCE PAPER; FEMALE; HUMAN; MAMMARY GLAND; MOLECULAR DYNAMICS; ONCOGENE; ORGANOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TISSUE DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 0033118806     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (85)

1. MacMahon, B., Cole, P., Lin, T. M., Lowe, C. R., Mirra, A. P., Ravnihar, B., Salber, E. J., Valaoras, V. G., and Yuasa, S. Age at first birth and breast cancer risk. Bull. WHO, 43: 209-221, 1970.
2. Russo, I. H., and Russo, J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylben(a)anthracene. J. Natl. Cancer Inst. (Bethesda), 61: 1439-1449, 1978.
3. Russo, J., Tay, L. K., and Russo, I. H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat., 2: 5-73, 1982.
4. Boice, J. D., Jr., and Monson, R. R. Breast cancer in women after repeated fluoroscopic examinations of the chest. J. Natl. Cancer Inst. (Bethesda), 59: 823-832, 1977.
5. Miller, A., Howe, G., Sherman, G., Lindsay, J., Yaffe, M., Dinner, P., Risch, H., and Preston, D. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N. Engl. J. Med., 321: 1285-1289, 1989.
6. Russo, J., Wilgus, G., and Russo, I. H. Susceptibility of the mammary gland to carcinogenesis. Am. J. Pathol., 96: 721-736, 1979.
7. Tokunga, M., Land, C., Tkuoka, S., Nishimori, I., Soda, M., and Akiba, S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat. Res., 138: 209-223, 1994.
8. Hildreth, N., Shore, R., and Dvoretsky, P. The risk of breast cancer after irradiation of the thymus in infancy. N. Engl. J. Med., 321: 1281-1284, 1989.
9. Knudson, A. G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993.
10. Hinds, P. W., and Weinberg, R. A. Tumor suppressor genes. Curr. Opin. Genet. Dev., 4: 135-141, 1994.
11. Kinzler, K., and Vogelstein, B. Gatekeepers and caretakers. Nature (Lond.), 386: 761-762, 1997.
12. Matzuk, M., and Bradley, A. Identification and analysis of tumor suppressor genes using transgenic mouse models. Semin. Cancer Biol., 5: 37-45, 1994.
13. Newman, B., Austin, M. A., Lee, M., and King, M-C. Inheritance of breast cancer: evidence for autosomal dominant transmission in high risk families. Proc. Natl. Acad. Sci. USA, 85: 1-5, 1988.
14. Claus, E. B., Risch, N., and Thompson, W. D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet., 48: 232-241, 1991.
15. Hall, J., Lee, M., Newman, B., Morrow, J., Anderson, L., Huey, B., and King, M-C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science (Washington DC), 250: 1684-1689, 1990.
16. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science (Washington DC), 266: 66-71, 1994.
17. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblance, J-F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C., Swedlund, B., Swensen, J., Teng, D., Thomas, A., Tran, T., Tran, T., Tranchant, M., Weaver-Feldhaus, J., Wong, A. K. C., Shizuya, H., Eyfjord, J. E., Cannon-Albright, L., Labrie, F., Skolnick, M. H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet., 12: 333-337, 1996.
18. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B. A. J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Egilsson, V., Barkadottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A., and Stratton, M. R. Identification of the breast cancer susceptibility gene, BRCA2. Nature (Lond.), 378: 789-792, 1995.
19. Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G. M., Lynch, H., Feunteun, J., Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Ormiston, W., McManus, R., Pye, C., Lewis, C. M., Cannon-Albright, L. A., Peto, J., Ponder, B. A. J., Skolnick, M. H., Easton, D. F., Goldgar, D. E., and Stratton, M. R. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (Washington DC), 265: 2088-2090, 1994.
20. Smith, S. A., Easton, D. G., Evans, D. G. R., and Ponder, B. A. J. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet., 2: 128-131, 1992.
21. Gudmundsson, J., Johannesdottir, G., Bergthorsson, J. T., Arason, A., Ingvarsson, S., and Egilsson, V. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12q13. Cancer Res., 55: 4830-4832, 1995.
22. Collins, N., McManus, R., Wooster, R., Mangion, J., Seal, S., and Lakhani, S. R. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene, 10: 1673-1675, 1995.
23. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swenson, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Söderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehart, J. D., Marks, J., Ballinger, D. G., Barrett, J. C., Skolnick, M. H., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
24. Lancaster, J. M., Wooster, R., Mangion, J., Phelan, C. M., Cochran, C., Gumbs, C., Seal, S., Barfoot, R., Collins, N., Bignell, G., Patel, S., Hamoudi, R., Larsson, C., Wiseman, R. W., Berchuck, A., Iglehart, J. D., Marks, J. R., Ashworth, A., Stratton, M. R., and Futreal, P. A. BRCA2 mutations in primary breast and ovarian cancers. Nat. Genet., 13: 238-240, 1996.
25. Miki, Y., Katagiri, T., Kasumi, F., Yoshimoto, T., and Nakamura, Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet., 13: 245-247, 1996.
26. Teng, D. H-F., Bogden, R., Mitchell, J., Baumgard, M., Bell, R., Berry, S., Davis, T., Ha, P. C., Kehrer, R., Jammulapati, S., Chen, Q., Offit, K., Skolnick, M. H., Tavtigian, S. V., Jhanwar, S., Swedlund, B., Wong, A. K. C., and Kamb, A. Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat. Genet., 13: 241-244, 1996.
27. Thomas, J., Smith, M., Tonkinson, J., Rubinfeld, B., and Polakis, P. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ., 8: 801-809, 1997.
28. Scully, R., Chen, J., Ochs, R., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90: 425-435, 1997.
29. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88: 265-275, 1997.
30. Sharan, S., Morimatsu, M., Albrecht, U., Lim, D-S., Regel, E., Sands, A., Eichele, G., Hasty, P., and Bradley, A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (Lond.), 386: 804-810, 1997.
31. Mizuta, R., LaSalle, J., Cheng, H., Shinohara, A., Ogawa, H., Copeland, N., Jenkins, N., Lalande, M., and Alt, F. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. USA, 94: 6927-6932, 1997.
32. Akc, W., Pero, R., Ormonde, P., Tavtigian, S., and Bartel, P. RAD51 interacts with the evolutionary conserved BRC motifs in the human breast cancer susceptibility gene BRCA2. J. Biol. Chem., 272: 31941-31944, 1997.
33. Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., and Venkitaraman, A. R. Involvement of Brca2 in DNA repair. Mol. Cell, 1: 347-357, 1998.
34. Connor, F., Bertwistle, D., Mee, P. J., Ross, G. M., Swift, S., Grigorieva, E., Tybulewicz, V. L. J., and Ashworth, A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet., 17: 423-430, 1997.
35. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G-Y., Abel, K. J., Weber, B. L., and Chodosh, L. A. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet., 11: 17-26, 1995.
36. Rajan, J. V., Marquis, S. T., Gardner, H. P., and Chodosh, L. A. Developmental expression of Brca2 colocalizes with Brca1 and is associated with differentiation in multiple tissues. Dev. Biol., 184: 385-401, 1997.
37. Blackshear, P., Goldsworthy, S., Foley, J., McAllister, K., Bennett, L., Collins, N., Bunch, D., Brown, P., Wiseman, R., and Davis, B. Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene, 16: 61-68, 1998.
38. Lane, T. F., Deng, C. X., Elson, A., Lyu, M. S., Kozak, C. A., and Leder, P. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev., 9: 2712-2722, 1995.
39. Rajan, J. V., Wang, M., Marquis, S. T., and Chodosh, L. A. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. USA, 93: 13078-13083, 1996.
40. Gudas, J., Li, T., Nguyen, H., Jensen, D., Rauscher, F. I., and Cowan, K. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ., 7: 717-723, 1996.
41. Gudas, J. M., Nguyen, H., Li, T., and Cowan, K. H. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res., 55: 4561-4565, 1995.
42. Chen, Y., Farmer, A., Chen, C-F., Jones, D., Chen, P-L., and Lee, W.-H. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res., 56: 3168-3172, 1996.
43. Ruffner, H., and Verma, I. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA, 94: 7138-7143, 1997.
44. Bertwistle, D., Swift, S., Marston, N., Jackson, L., Crossland, S., Crompton, M., Marshall, C., and Ashworth, A. Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res., 57: 5485-5488, 1998.
45. Vaughn, J., Davis, P., Jarboe, M., Huper, G., Evans, A., Wiseman, R., Berchuck, A., Iglehart, J., Futreal, P., and Marks, J. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ., 7: 711-715, 1996.
46. Vaughn, J., Cirisano, F., Huper, G., Berchuck, A., Futreal, P., Marks, J., and Iglehart, J. Cell cycle control of BRCA2. Cancer Res., 56: 4590-4594, 1996.
47. Yamamoto, A., Taki, T., Yagi, H., Habu, T., Yoshida, K., Yoshimura, Y., Yamamoto, K., Matsushiro, A., Nishimune, Y., and Morita, T. Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells. Mol. Gen. Genet., 251: 1-12, 1996.
48. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54: 105-115, 1988.
49. Muller, W. J., Lee, F. S., Dickson, C., Peters, G., Pattengale, P., and Leder, P. The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J., 9: 907-913, 1990.
50. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., and Leder, P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell, 49: 465-475, 1987.
51. Wilks, A. F., Kurban, R. R., Hovens, C. M., and Ralph, S. J. The application of the polymerase chain reaction to cloning members of the protein tyrosine kinase family. Gene, 85: 67-74, 1989.
52. Wilks, A. F. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 86: 1603-1607, 1989.
53. Hanks, S. K., Quinn, A. M., and Hunter, T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science (Washington DC), 241: 42-52, 1988.
54. Stairs D. B., Gardner H. P., Ha S. I., Copeland N. G., Gilbert D. J., Jenkins N. A., and Chodosh L. A. Cloning and characterization of Krct, a member of a novel subfamily of serine/threonine kinases. Hum. Mol. Genet., 7: 2157-2166, 1998.
55. Nairn, A., and Piciotto, M. Calcium/calmodulin-dependent protein kinases. Semin. Cancer Biol., 5: 295-303, 1994.
56. Yuan, J-M., Yu, M. C., Ross, R. K., Gao, Y-T., and Henderson, B. E. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res., 48: 1949-1953, 1988.
57. Paffenbarger, R. S. J., Kampert, J. B., and Chang, H-G. Characteristics that predict risk of breast cancer before and after the menopause. Am. J. Epidemiol., 112: 258-268, 1980.
58. Wang, Q-S., Ross, R. K., Yu, M. C., Ning, J. P., Henderson, B. E., and Kimm, H. T. A case-control study of breast cancer in Tianjin, China. Cancer Epidemiol. Biomark. Prev., 1: 435-439, 1992.
59. Lubin, J. H., Burns, P. E., Blot, W. J., Lees, A. W., May, C., Morris, L. E., and Fraumeni, J. F., Jr. Risk factors for breast cancer in women in northern Alberta, Canada, as related to age at diagnosis. J. Natl. Cancer Inst. (Bethesda), 68: 211-217, 1982.
60. MacMahon, B., Purde, M., Cramer, D., and Hint, E. Association of breast cancer risk with age at first and subsequent births: a study in the population of the Estonian republic. J. Natl. Cancer Inst. (Bethesda), 69: 1035-1038, 1982.
61. Layde, P. M., Webster, L. A., Baughman, A. L., Wingo, P. A., Rubin, G. L., and Ory, H. W. The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. J. Clin. Epidemiol., 42: 963-973, 1989.
62. Rosner, B., and Colditz, G. A. Nurses' Health Study: log-incidence mathematical model of breast cancer incidence. J. Natl. Cancer Inst. (Bethesda), 88: 359-364, 1996.
63. Rosner, B., Colditz, G. A., and Willett, W. C. Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am. J. Epidemiol., 139: 819-835, 1994.
64. Brinton, L. A., Hoover, R., and Fraumeni, J. F. J. Reproductive factors in the aetiology of breast cancer. Br. J. Cancer, 47: 757-762, 1983.
65. Newcomb, P., Storer, B., Longnecker, M., Mittendorf, R., Greenberg, E., Clapp, R., Burke, K., Willett, W., and MacMahon, B. Lactation and a reduced risk of premenopausal breast cancer. N. Engl. J. Med., 330: 81-87, 1994.
66. Michels, K., Hsieh, C., Trichopoulos, D., and Willett, W. Abortion and breast cancer risk in seven countries. Cancer Causes Control, 6: 75-82, 1995.
67. Daling, J., Malone, K., Voigt, L., White, E., and Weiss, N. Risk of breast cancer among young women: relationship to induced abortion. J. Natl. Cancer Inst. (Bethesda), 86: 1584-1592, 1994.
68. Melbye, M., Wohlfahrt, J., Olsen, J. H., Frisch, M., Westergaard, T., Helweg-Larsen, K., and Andersen, P. K. Induced abortion and the risk of breast cancer. N. Engl. J. Med., 336: 81-85, 1997.
69. Salber, E. J., Trichopoulos, D., and MacMahon, B. Lactation and reproductive histories of breast cancer patients in Boston 1965-66. J. Natl. Cancer Inst. (Bethesda), 43: 1013-1024, 1969.
70. Russo, J., Rivera, R., and Russo, I. H. Influence of age and parity on the development of the human breast. Breast Cancer Res. Treat., 23: 211-218, 1992.
71. Russo, J., and Russo, I. H. Development pattern of human breast and susceptibility to carcinogenesis. Eur. J. Cancer Prev., 2 (Suppl. 3): 85-100, 1993.
72. Boone, C., and Kelloff, G. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia. J. Cell. Biochem. Suppl., 19: 10-22, 1994.
73. Dhingra, K., Vogel, V., Sneige, N., Sahin, A., Aldaz, M., Hortobagyi, G., and Hittelman, W. Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials. J. Cell. Biochem., 17G: 37-43, 1993.
74. Kelloff, G., Boone, C., Steele, V., Crowell, J., Lubet, R., Doody, L., and Greenwald, P. Development of breast cancer chemopreventive drugs. J. Cell. Biochem., 17G: 2-13, 1993.
75. Love, R. Approaches to the prevention of breast cancer. J. Clin. Endocrinol. Metab., 80: 1757-1760, 1995.
76. Daniel, C., and Silberstein, G. Postnatal development of the rodent mammary gland. In: M. Neville and C. Daniel (eds.), The Mammary Gland: Development, Regulation, and Function, pp. 3-36. New York: Plenum Press, 1987.
77. Russo, J., Gusterson, B. A., Rogers, A. E., Russo, I. H., Wellings, S. R., and van Zwieten, M. Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62: 244-278, 1990.
78. Russo, J., Saby, J., Isenberg, W. M., and Russo, I. H. Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz[a]anthracene. J. Natl. Cancer Inst. (Bethesda), 59: 435-445, 1977.
79. Moon, R. C. Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int. J. Cancer, 4: 312-317, 1969.
80. Moon, R. C. Influence of pregnancy and lactation on experimental mammary carcinogenesis. In: M. C. Pike, P. K. Siiteri, and C. W. Welsch (eds.), Hormones and Breast Cancer, pp. 353-364. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1981.
81. Dao, T. L. Mammary cancer induction by 7,12-dimethylbenz[a]anthracene: relation to age. Science (Washington DC), 165: 810-811, 1969.
82. Huggins, C., Grand, L. C., and Brillantes, F. P. Critical significance of breast structure in the induction of mammary cancer in the rat. Proc. Natl. Acad. Sci. USA, 45: 1294-1300, 1959.
83. Huggins, C., Briziarelli, G., and Sutton, H. Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J. Exp. Med., 109: 25-42, 1959.
84. Russo, J., and Russo, I. H. Biological and molecular bases of mammary carcinogenesis. Lab. Invest., 57: 112-137, 1987.
85. Robinson, G. W., McKnight, R. A., Smith, G. H., and Hennighausen, L. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development (Camb.), 121: 2079-2090, 1995.